Honda warns of historic annual loss on global EV downturn
The carmaker’s strategy rethink will see it cancel the development and launch of three EV models that had been planned for North America, it said Thursday.
Bloomberg News
Articles
Generic Ozempic could cost less than $3 a month, study shows
Generic Ozempic is set to emerge in major markets from India and Brazil to China and Canada this year, reshaping the sector in those countries.
Soaring power prices have US politicians searching for solutions
President Trump wants the companies to sign pledges committing to foot the power bill for energy-hungry data centers, which are blamed for driving up electricity costs.
Bessent says Trump’s tariff hike to 15% likely coming this week
President Trump last month put a 10% universal levy in place after the Supreme Court invalidated most of his previous tariff regime.
Live Nation’s antitrust trial kicks off before federal jury
The largest U.S. venue owner and ticket seller faces claims by the U.S. Justice Department and more than three dozen states that it is illegally monopolizing the live music industry and should be forced to shed its Ticketmaster unit.
Stellantis CEO sees return to profit in North America region
Filosa said he was optimistic about swinging back to profit in North America, where the company reported a $1.1 billion loss during the second half of the year, following writedowns and charges.
AI threatens staffing industry as companies bring recruitment in-house
Advances in AI are allowing employers to screen resumes, rank applicants and conduct preliminary interviews without relying on external recruiters.
Novo Nordisk says it’s suing Hims to halt obesity drug copycats
The makers of blockbuster GLP-1 drugs, Novo and Indianapolis-based Eli Lilly and Co., have long complained the U.S. Food and Drug Administration hasn’t done enough to stop the proliferation of cheap, compounded weight-loss drugs.
Traders chase ‘AI resistant’ stocks as disruption fear hits tech
A new group of stock winners has emerged as technology shares slide: Companies with businesses that artificial intelligence can’t replicate.
Stellantis shares plunge on $26B in charges tied to EV retreat
The writedowns, much of which will cover the cost of canceling EVs and compensating suppliers, exceed the impairments Ford Motor Co., General Motors Co. and Porsche AG have announced in recent months.
Walmart joins $1T club as tech, frugal shoppers fuel gains
Recent investments in artificial intelligence have helped supercharge the stock’s advance.
UPDATE: Elevance shares wobble on Trump administration plans, lower projections
In a call with shareholders Wednesday, Elevance CEO Gail Boudreaux said the Trump administration’s plan to limit federal payments to Medicare Advantage “doesn’t keep pace with the current medical cost and utilization trends.”
Travel chaos set to linger as airlines try to restore flights
Sunday marked the highest number of cancellations since the early days of the COVID pandemic.
Fed served with DOJ subpoenas; Powell vows to stand firm
The unprecedented move by the Trump administration marks an escalation of the president’s longstanding feud with the central bank’s chair, though Trump denied having any knowledge of an investigation.
Eli Lilly set to back Aktis Oncology’s upsized $318M IPO
Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.
Copper set for biggest annual gain since 2009 on supply bets
The rise is being fueled by near-term supply tightness and bets that demand for the metal key in electrification will outpace production.
Tariffs to set up US materials stocks for best earnings in 5 years
Materials stocks—a group of companies ranging from steelmaker Nucor Corp. and paint maker Sherwin-Williams Co. to packaging manufacturers including Smurfit WestRock Plc and Ball Corp.—are set to see earnings rise 20% in 2026.
Bots, banking and stablecoins expected to dominate fintech in 2026
After a year of regulatory triumphs, industry leaders are betting that 2026 could mark a major inflection point.
Every Wall Street analyst now predicts a stock rally in 2026
After three years when the equity market’s rip-roaring run made a mockery of any bearish calls, sell-side strategists are marching in lockstep optimism for 2026.
This year’s IPO billionaires see wealth eroded by market moves
The long-awaited return of IPO activity this year minted 21 new billionaires, but what came after many companies’ eye-popping debuts was often a different story.